Ładuje się......
Beyond abiraterone: New hormonal therapies for metastatic castration-resistant prostate cancer
Prostate cancer is a heterogeneous disease where the previous concept of “hormone resistance” has been changed by a new generation of hormonal therapies that have proven efficacy in the castration-resistant setting. The fact is that androgens play a crucial role in the whole clinical course of prost...
Zapisane w:
1. autor: | |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
Landes Bioscience
2014
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928129/ https://ncbi.nlm.nih.gov/pubmed/24100689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26724 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|